The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of pre-existing diabetes mellitus on acute care use in older patients with metastatic prostate cancer on androgen receptor signaling inhibitors.
 
Michael Liu
No Relationships to Disclose
 
Rohit Raghunathan
No Relationships to Disclose
 
Karie Runcie
Consulting or Advisory Role - Johnson & Johnson/Janssen
 
Shikun Wang
No Relationships to Disclose
 
Jason Wright
Honoraria - American College of Obstetricians and Gynecologists; UpToDate
Consulting or Advisory Role - UpToDate
Research Funding - Merck (Inst)
 
Alexander Wei
Research Funding - IDEAYA Biosciences (Inst); Novartis (Inst); Pyxis (Inst); Regeneron (Inst)
 
Mark Stein
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Exelixis; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Vaccitech; Xencor
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals; Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Regeneron (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)
 
Dawn Hershman
Consulting or Advisory Role - AIM Specialty Health